IRINOTECAN INTAS irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial

Страна: Австралія

мова: англійська

Джерело: Department of Health (Therapeutic Goods Administration)

Активний інгредієнт:

irinotecan hydrochloride trihydrate, Quantity: 300 mg

Доступна з:

Accord Healthcare Pty Ltd

Фармацевтична форма:

Injection, concentrated

Склад:

Excipient Ingredients: hydrochloric acid; sodium hydroxide; lactic acid; water for injections; sorbitol

Адміністрація маршрут:

Intravenous Infusion

Одиниць в упаковці:

1

Тип рецепту:

(S4) Prescription Only Medicine

Терапевтичні свідчення:

Irinotecan hydrochloride is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum. Irinotecan hydrochloride is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

Огляд продуктів:

Visual Identification: A pale yellow clear solution; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Статус Авторизація:

Registered

Дата Авторизація:

2020-03-05